Rankings
▼
Calendar
ENGN FY 2023 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena
ENGN
enGene Holdings Inc.
$359M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$175,000
Operating Income
-$26M
Net Income
-$100M
EPS (Diluted)
$-4.24
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$25M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$87M
Total Liabilities
$14M
Stockholders' Equity
$72M
Cash & Equivalents
$82M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$175,000
$0
—
Operating Income
-$26M
-$2M
-1322.9%
Net Income
-$100M
$30,726
-325287.1%
← Q4 2022
All Quarters
Q1 2023 →